GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Research & Development

Veritas In Silico (TSE:130A) Research & Development : 円104.4 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Veritas In Silico's Research & Development for the three months ended in Dec. 2024 was 円0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was 円104.4 Mil.

Veritas In Silico Research & Development Historical Data

The historical data trend for Veritas In Silico's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Research & Development Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Research & Development
129.10 148.33 136.55 172.48

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24
Research & Development Get a 7-Day Free Trial - 34.15 33.65 36.59 -

Veritas In Silico Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円104.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veritas In Silico  (TSE:130A) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Veritas In Silico Research & Development Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Veritas In Silico Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Research & Development
Comparable Companies
TSE:4598 TSE:4576 TSE:4570 TSE:4591 TSE:4572 TSE:4584 TSE:4891 TSE:4594 TSE:4884 TSE:4881 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Website
https://www.veritasinsilico.com
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines